Your cart is currently empty!
Blog
Octreotide
Description
This page contains brief details about the drug octreotide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Octreotide has been approved to treat acromegaly by the U.S. FDA approved on June 26, 2020.
Mechanism of Action of Octreotide
Somatostatin is a hormone produced by the body on its own. It reduces or stops the production of several hormones, including insulin and gut hormones, and it also regulates the stomach and intestinal emptying.
Octreotide is a somatostatin analog that is made synthetically and slows down hormone production. It helps ease carcinoid syndrome, a type of cancer called carcinoid tumors that release certain chemicals into your bloodstream and slows the spread of the tumor. Flushing of the skin, diarrhea, and stomach pain are a few of the symptoms of carcinoid syndrome you could experience.
Uses of Octreotide
Octreotide treats acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors (VIPoma).
Octreotide Dosage available
Octreotide is available as an immediate-release solution (liquid) for injection in the doses of 10 mg, 20 mg, and 30 mg. It is intended for administration via the subcutaneous or intravenous route. It must be administered only under the supervision of a healthcare professional at around the same time every day. Check for discoloration and the presence of particles before injecting.
Pegaspargase
Description
This page contains brief details about the drug pegaspargase, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Pegaspargase is a chemotherapy drug containing the active constituent pegaspargase. It is used to treat a type of blood cancer called Acute Lymphoblastic Leukemia (ALL).This is a white blood cell cancer in which the immature white cells start growing out of control, thus preventing the production of functional blood cells. Combined with other chemotherapy drugs, this medication can help increase the chances of remission and long-term survival for people with ALL.
Pegaspargase received its initial FDA approval in 1994 for treating leukemia. Since then, it has also been approved for use in various other countries. This medication is a prescription medication and should only be used under the supervision of a healthcare provider. It is particularly effective in treating children with ALL, who have a higher rate of remission and overall survival when included in their treatment plan.
Mechanism of Action of Pegaspargase
Pegaspargase is an enzyme that breaks down the amino acid asparagine in the body. Cancer cells require asparagine to grow and divide and cannot produce their asparagine. By breaking down asparagine in the body, this medication can effectively “starve” cancer cells of this essential nutrient, slowing their growth and promoting cancer cell death. However, normal cells in the body can produce their asparagine and are not as affected by the enzyme as cancer cells. Therefore, this medicine selectively targets cancer cells while sparing healthy cells in the body to some extent.
Uses of Pegaspargase
Pegaspargase is an antineoplastic agent used to treat certain types of cancer, particularly acute lymphoblastic leukemia (ALL) and Non- Hodgkin’s lymphoma.
Pegaspargase Dosage available
Pegaspargase is an enzyme that breaks down the amino acid asparagine in the body. Cancer cells require asparagine to grow and divide and cannot produce their asparagine. By breaking down asparagine in the body, this medication can effectively “starve” cancer cells of this essential nutrient, slowing their growth and promoting cancer cell death. However, normal cells in the body can produce their asparagine and are not as affected by the enzyme as cancer cells. Therefore, this medicine selectively targets cancer cells while sparing healthy cells in the body to some extent.
Micafungin
Description
This page contains brief details about the drug micafungin, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Micafungin was initially approved by the United States Food and Drug Administration (FDA) on January 17, 2005.
Mechanism of Action of Micafungin
Micafungin works by inhibiting the synthesis of a crucial component in the fungal cell wall called beta-glucan. This disruption weakens the structural integrity of the cell wall, leading to increased permeability and ultimately causing the death of the fungal cell.
Uses of Micafungin
Micafungin is used to treat a range of serious fungal infections caused by specific types of fungi. It is indicated for the treatment of invasive candidiasis, including candidemia, intra-abdominal candidiasis, and infections of the esophagus caused by Candida species. Additionally, it is used for the treatment of invasive aspergillosis and to initiate empirical antifungal therapy in certain circumstances. It is also used in managing fever in patients with low white blood cell counts (neutropenic fever) often associated with chemotherapy.
Micafungin Dosage available
Micafungin works by inhibiting the synthesis of a crucial component in the fungal cell wall called beta-glucan. This disruption weakens the structural integrity of the cell wall, leading to increased permeability and ultimately causing the death of the fungal cell.
Meropenem
Description
This page contains brief details about the drug meropenem, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Meropenem is an antibiotic medication developed by the U.S. Food And Drug Administration and initially approved in the year 1996, for treating various bacterial infections caused by susceptible organisms.
Mechanism of Action of Meropenem
Meropenem is used to treat various bacterial infections caused by susceptible organisms. This injection also treats skin, lung, urine, and gynecological infections. Mostly, it can be used during the prevention of surgical site infections.
Uses of Meropenem
Meropenem works by inhibiting the growth of bacteria and preventing them from multiplying. It does this by interfering with the bacterial cell wall synthesis, which is essential for survival.
Meropenem Dosage available
Meropenem will be administered to you by a healthcare professional in a hospital setting. It is usually administered as an intravenous injection into a vein. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
Lenvatinib
Description
This page contains brief details about the drug lenvatinib, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Lenvatinib is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment. Patients who have had an allergic reaction to lenvatinib or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking this medication, as it can impair wound healing and increase the risk of bleeding.
Lenvatinib was first approved by the United States Food and Drug Administration (FDA) in February 2015 for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer. Since then, it has received additional approvals for other indications, including the treatment of hepatocellular carcinoma (liver cancer) and renal cell carcinoma (kidney cancer).
Mechanism of Action of Lenvatinib
Lenvatinib blocks the enzyme receptor tyrosine kinases (RTKs). RTKs develop new blood vessels that supply oxygen and nutrients to the cells and help them grow. This medicine inhibits the receptors that facilitate the growth of blood vessels in tumor cells. RTKs are present in high concentrations in cancer cells, and administration of this medicine slows down the rate of cancer cells’ growth and multiplication.
Uses of Lenvatinib
Lenvatinib is a medication that is used to treat several types of cancer, including thyroid, liver, and kidney cancer. In patients with radioactive iodine-refractory differentiated thyroid cancer, it can be used to slow the progression of the disease and reduce tumor size. It is also approved for the treatment of unresectable hepatocellular carcinoma (HCC), which is the most common type of liver cancer.
Lenvatinib Dosage available
Lenvatinib is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up the second dose.
Peg L-Asparaginase
Description
This page contains brief details about the drug peg l-asparaginase, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects
Date of Approval
Peg-L-Asparaginase is a class of antitumor drug that belongs to the category of medicines known as enzymes known as hydrolases. It was approved on 30 June 2021 to treat Acute Lymphoblastic Leukaemia.
Mechanism of Action of Peg L-Asparaginase
Cancer cells need a substance called asparagine to survive. This Injection works by lowering the levels of asparagine in the body.
Uses of Peg L-Asparaginase
Peg-L-Asparaginase is used to treat Acute Lymphoblastic Leukaemia (a type of cancer of the white blood cells).
Peg L-Asparaginase Dosage available
It will be given to you by your health care professional. Do not self-administer. Your physician will decide the dose and duration of your treatment based on the disease severity and other factors.
Ibrutinib
Description
This page contains brief details about the drug ibrutinib, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
The U.S. FDA approved Ibrutinib as the first Bruton tyrosine kinase inhibitor (BTK) to treat several types of blood cancers on13th November 2013.
Mechanism of Action of Ibrutinib
Ibrutinib Capsule is a biological agent that acts as targeted drug therapy in cancer treatment. It is classified as a Bruton tyrosine kinase inhibitor belonging to the class of kinase inhibitors. Bruton tyrosine kinase is a protein that acts as a driving force for chronic lymphocytic leukemia and other B cell cancers. Ibrutinib acts against the enzymatic activity of BTK, further inhibiting its signaling. Thus, the number of cancer cells reduces and results in a delay in disease progression.
Uses of Ibrutinib
Ibrutinib Capsule has been developed to treat several types of blood cancers, such as Chronic lymphocytic leukemia (CLL), Mantle cell lymphoma, Waldenstrom’s macroglobulinemia, small lymphocytic lymphoma (SLL) and chronic graft versus host disease.
Ibrutinib Dosage available
The recommended dose of Ibrutinib is one capsule a day. Ibrutinib is available as a 140mg capsule. Swallow the entire capsule with water and do not open, dissolve or chew them. Take the capsule at the same time each day with food or between meals. Your physician will choose the dosage and administration frequency based on your medical condition because it differs for each person.
Flucytosine
Description
This page contains brief details about the drug flucytosine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Flucytosine is an anti-fungal drug developed by the U.S. Food And Drug Administration and initially approved for treating fungal infections.
Mechanism of Action of Flucytosine
Flucytosine works by interfering with the synthesis of fungal DNA and RNA. This disrupts the growth and replication of fungal cells, helping to control and eliminate the infection.
Uses of Flucytosine
Flucytosine is used to treat serious fungal infections caused by specific types of fungi. It is considered an important component in managing infections caused by fungi like Cryptococcus and Candida species, which can be particularly problematic in individuals with weakened immune systems. It’s often combined with other antifungal drugs to enhance treatment effectiveness.
Flucytosine Dosage available
Take the Flucytosine as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Exemestane
Description
This page contains brief details about the drug exemestane, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Exemestane is an anticancer medication that was approved for its medical use on 21st October 1999.
Mechanism of Action of Exemestane
Exemestane is a steroidal agent that belongs to the class of third-generation aromatase inhibitors. The aromatase enzyme is responsible for producing the female sex hormone estrogen. Exemestane irreversibly inactivates the aromatase enzyme, lowers estrogen production, and ultimately slows the development of cancer cells.
Uses of Exemestane
Exemestane Tablet has been developed to treat early and advanced breast cancer in postmenopausal women who have taken Tamoxifen and other treatments before.
Exemestane Dosage available
Exemestane is available as a tablet in a dose of 25mg. Take Exemestane Tablet once a day after food.